DL-Cystine is a sulfur-containing, non-proteinogenic amino acid derivative in the form of a disulfide-linked dimer composed of two cysteine residues joined through a cystine disulfide bond, with the overall structure bearing two amino groups and two carboxyl groups per molecule. The molecule contains a central disulfide (-S-S-) functionality that can undergo redox interconversion with thiol-containing cysteine species under appropriate conditions, and it is provided as the DL mixture indicating racemic composition rather than a single stereochemical enantiomer. In research and peptide chemistry workflows, DL-Cystine is used as a defined cystine source for preparing cystine-containing peptide building blocks, studying disulfide exchange and redox behavior, and supporting analytical or labeling approaches that require a controlled disulfide functional handle.
DL-Cystine is a disulfide-linked amino acid dimer composed of two cysteine units joined through an S-S bond, presenting a chiral, redox-active sulfur framework within a symmetrical dipeptide-like scaffold. The molecule contains two amino groups and two carboxylic acid functionalities in the native cystine connectivity, enabling salt formation and controlled solubility depending on pH and counterion selection. The disulfide bond can undergo reversible reduction to cysteine derivatives and can also participate in thiol-disulfide exchange, making DL-Cystine a practical sulfur-containing building block for amino acid derivatization and redox chemistry. The DL designation reflects racemic stereochemistry at the cysteine stereocenters, which influences stereochemical outcomes in downstream coupling, oxidation state control, and peptide or biomolecule labeling workflows.
1. Peptide Synthesis
DL-Cystine functions as a sulfur-containing amino acid precursor for peptide assembly strategies that require disulfide connectivity or cystine-derived side-chain architecture. The disulfide linkage and the presence of amino and carboxyl groups allow incorporation into synthesis routes where cystine units are introduced as protected or activated fragments, followed by controlled redox handling to achieve the desired disulfide pattern. Racemic stereochemistry may be leveraged when stereochemical purity is not the primary determinant, while subsequent oxidation or exchange steps can be used to establish disulfide bonds in peptide analogs. Downstream peptide building block preparation and disulfide-stapled scaffold construction can be supported by the redox reactivity of the S-S bond under peptide-manufacturing compatible conditions.
2. Chemical Biology Labeling
DL-Cystine is suitable for chemical biology workflows that exploit thiol-disulfide exchange to introduce or reshuffle sulfur-based linkages on proteins, peptides, or other biomolecules. The disulfide bond can serve as a controlled handle for redox-mediated conjugation chemistry, while the amino acid functional groups support formation of salts and intermediates used in labeling reagent synthesis. Racemic stereochemistry typically does not hinder the formation of disulfide-linked adducts when the target is a connectivity pattern rather than a stereochemically defined chiral environment. Biomolecule modification and assay reagent generation can be designed around cystine-derived sulfur chemistry to enable subsequent analytical readouts or conjugate construction.
3. Process Chemistry Intermediate
DL-Cystine can be employed in process chemistry intermediate preparation where sulfur-rich amino acid feedstocks are required for downstream transformations such as reduction to thiol-bearing species or conversion into activated cysteine analogs. The disulfide motif provides a chemically distinct redox handle that can be routed through controlled reduction/oxidation sequences to access thiol intermediates for further functionalization. The amino and carboxyl functionalities enable straightforward derivatization into salts, esters, or protected forms that integrate into manufacturing-scale synthetic planning for fine chemicals. Industrial bioprocessing and specialty chemical production may use cystine as a sulfur source for generating reactive sulfur intermediates that feed into larger synthetic programs.
4. Redox-Active Derivatization
DL-Cystine supports amino acid derivatization programs focused on redox-active sulfur chemistry, including generation of cysteine derivatives via disulfide reduction and subsequent re-oxidation to re-form disulfide linkages. The S-S bond enables reversible interconversion between disulfide and thiol states, which can be used to tune reactivity profiles for functional group installation, linker design, or controlled crosslinking. The molecule's bifunctional amino acid framework can be transformed into protected amino acid derivatives or activated intermediates that participate in coupling chemistry and downstream assembly steps. Redox-controlled intermediate formation and thiol/disulfide exchange-based scaffold editing can be applied in both synthetic methodology development and applied amino acid chemistry.
5. Analytical Research Standards
DL-Cystine is appropriate for analytical research where sulfur-containing amino acid standards and reference materials are required to monitor reduction/oxidation state, disulfide integrity, and amino acid composition in complex matrices. The defined disulfide connectivity and the presence of amino acid functional groups support method development for chromatographic separation and detection of cystine-related species, including reduced cysteine forms generated during sample preparation. Racemic stereochemistry can be acceptable for quantitative assays that target connectivity and elemental composition rather than enantiomeric purity. Analytical standard development for peptide and protein studies can be supported by cystine's chemically stable disulfide identity alongside its predictable redox interconversion behavior.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More